Tubidy

Shuren Fda

Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule

Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule

4:36 |
Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?

Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?

4:58 |
EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going

EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going

29:01 |
Jeff Shuren of the FDA at the 2023 Utah Life Sciences Summit

Jeff Shuren of the FDA at the 2023 Utah Life Sciences Summit

45:24 |
CDRH Center Director Jeff Shuren on why FDA invests in MDIC

CDRH Center Director Jeff Shuren on why FDA invests in MDIC

0:56 |
US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum

US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum

10:51 |
Interview with Director of the FDA's CDRH medical device division, Dr. Shuren

Interview with Director of the FDA's CDRH medical device division, Dr. Shuren

8:51 |
Media Call: COVID-19 Variant Guidances – 2/22/2021

Media Call: COVID-19 Variant Guidances – 2/22/2021

32:20 |
What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?

What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?

6:16 |
2024 CERSI Summit - Panel 4: FDA Center Directors Forum

2024 CERSI Summit - Panel 4: FDA Center Directors Forum

44:16 |
Conversation with Dr. Jeff Shuren

Conversation with Dr. Jeff Shuren

48:09 |
What's most important for innovators to understand about FDA's new mobile health guideline?

What's most important for innovators to understand about FDA's new mobile health guideline?

3:01 |
MDUFA IV and Beyond: Video Reports

MDUFA IV and Beyond: Video Reports

9:24 |
Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers

Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers

4:16 |
MEDIA CALL: FDA’s Final Rule on Laboratory Developed Tests – 04/29/2024

MEDIA CALL: FDA’s Final Rule on Laboratory Developed Tests – 04/29/2024

30:40 |
07/18/2018 - Session VI: Shuren

07/18/2018 - Session VI: Shuren

13:41 |
FDA 2022 Preview

FDA 2022 Preview

2:58:07 |
FDA Updated QSR – 21 CFR, Part 820 Information

FDA Updated QSR – 21 CFR, Part 820 Information

1:21 |
FDA Townhall California 2011 David Kennedy and Stacy Case Testimony

FDA Townhall California 2011 David Kennedy and Stacy Case Testimony

6:55 |
FDA Roundtable

FDA Roundtable

48:31 |
← Previous
2
Next →